TEVA HIGHLIGHTS NEW REAL-WORLD DATA SHOWING UZEDY® (RISPERIDONE) OUTPERFORMS OTHER LONG-ACTING INJECTABLES IN KEEPING SCHIZOPHRENIA PATIENTS ON TREATMENT, WHILE REDUCING EMERGENCY CARE AND HEALTHCARE COSTS

Reuters · 1d ago

Please log in to view news